Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 14Recruiting 5Completed 3Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 3OTHER_GOV 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 1774Neoplasms 1501Carcinoma, Non-Small-Cell Lung 1043Prostatic Neoplasms 957Colorectal Neoplasms 878Lung Neoplasms 800Pancreatic Neoplasms 572Carcinoma, Hepatocellular 542Leukemia, Myeloid, Acute 541Stomach Neoplasms 512Ovarian Neoplasms 507Neoplasm Metastasis 496Multiple Myeloma 495Recurrence 413Melanoma 386Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 355Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 305Endometrial Neoplasms 304Triple Negative Breast Neoplasms 299Glioblastoma 298Rectal Neoplasms 280Urinary Bladder Neoplasms 264Sarcoma 264Hematologic Neoplasms 264Colonic Neoplasms 254

Interventions

Liver Transplantation 1Diagnostic Imaging 1Carvedilol 16-acetylaminocaproic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Hypertension, Portal × Clear all
NCT06265272 2025-09-26

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Massachusetts General Hospital

Recruiting
45 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

NCT05339984 2025-06-27

LSM

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting
150 enrolled

Fibrosis, Hypertension, Portal, Liver Diseases

NCT06594744 2025-02-13

P-HCC-CVL

Taipei Veterans General Hospital, Taiwan

Phase 4 Recruiting
120 enrolled
Gastrointestinal

Esophageal and Gastric Varices, Carcinoma, Hepatocellular, Hypertension, Portal

NCT06434753 2024-06-04

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT05502198 2023-08-24

ACCESS-ESLD

Linkoeping University

Recruiting
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡